PRISM BioLab Co.,LTD (206A.T)

JPY 242.0

(-2.02%)

Revenue Summary of PRISM BioLab Co.,LTD

  • PRISM BioLab Co.,LTD's latest annual revenue in 2023 was 112.92 Million JPY , down -79.63% from previous year.
  • PRISM BioLab Co.,LTD's latest quarterly revenue in 2024 Q3 was 99.67 Million JPY , down 0.0% from previous quarter.
  • PRISM BioLab Co.,LTD reported a annual revenue of 554.39 Million JPY in annual revenue 2022, down 0.0% from previous year.
  • PRISM BioLab Co.,LTD reported a quarterly revenue of 112.92 Million JPY for 2023 FY, down -79.63% from previous quarter.
  • PRISM BioLab Co.,LTD reported a quarterly revenue of 554.39 Million JPY for 2022 FY, down 0.0% from previous quarter.

Annual Revenue Chart of PRISM BioLab Co.,LTD (2023 - 2022)

Historical Annual Revenue of PRISM BioLab Co.,LTD (2023 - 2022)

Year Revenue Revenue Growth
2023 112.92 Million JPY -79.63%
2022 554.39 Million JPY 0.0%

Peer Revenue Comparison of PRISM BioLab Co.,LTD

Name Revenue Revenue Difference
KOHJIN BIO CO LTD 4.77 Billion JPY 97.633%
GNI Group Ltd. 26.01 Billion JPY 99.566%
Linical Co., Ltd. 12.3 Billion JPY 99.082%
Trans Genic Inc. 13.08 Billion JPY 99.137%
MEDINET Co., Ltd. 661.54 Million JPY 82.93%
Soiken Holdings Inc. 5.15 Billion JPY 97.811%
Cytori Cell Research Institute, Inc. 1.56 Billion JPY 92.763%
AnGes, Inc. 152.98 Million JPY 26.185%
OncoTherapy Science, Inc. 610.11 Million JPY 81.491%
Nxera Pharma Co., Ltd. 12.76 Billion JPY 99.115%
Immuno-Biological Laboratories Co., Ltd. 816.7 Million JPY 86.173%
NanoCarrier Co., Ltd. 135.5 Million JPY 16.665%
Carna Biosciences, Inc. 1.62 Billion JPY 93.055%
CanBas Co., Ltd. - JPY -Infinity%
D. Western Therapeutics Institute, Inc. 428.36 Million JPY 73.638%
RaQualia Pharma Inc. 1.9 Billion JPY 94.06%
Chiome Bioscience Inc. 682.46 Million JPY 83.453%
Kidswell Bio Corporation 2.43 Billion JPY 95.355%
PeptiDream Inc. 28.71 Billion JPY 99.607%
Oncolys BioPharma Inc. 63.03 Million JPY -79.14%
Ribomic Inc. - JPY -Infinity%
SanBio Company Limited - JPY -Infinity%
Healios K.K. 121 Million JPY 6.673%
BrightPath Biotherapeutics Co., Ltd. 72 Thousand JPY -156741.667%
Kubota Pharmaceutical Holdings Co., Ltd. 39.88 Million JPY -183.115%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM - JPY -Infinity%
CellSource Co., Ltd. 4.51 Billion JPY 97.496%
FunPep Company Limited 530 Thousand JPY -21206.792%
Kringle Pharma, Inc. 69.25 Million JPY -63.07%
Stella Pharma Corporation 269.49 Million JPY 58.097%
TMS Co., Ltd. - JPY -Infinity%
Noile-Immune Biotech Inc. 316.81 Million JPY 64.356%
Cuorips Inc. 23.1 Million JPY -388.815%
K Pharma,Inc. 1 Billion JPY 88.707%
Takara Bio Inc. 43.5 Billion JPY 99.74%
ReproCELL Incorporated 2.42 Billion JPY 95.347%
PhoenixBio Co., Ltd. 1.71 Billion JPY 93.417%
StemCell Institute Inc. 2.48 Billion JPY 95.449%
Japan Tissue Engineering Co., Ltd. 2.51 Billion JPY 95.508%
CellSeed Inc. 190.13 Million JPY 40.607%